New in the Library (May – June 2026)
Here are the latest items added to the CTN Dissemination Library for May – June 2026 (this post will be updated as new items come in):
Probability of fentanyl adulteration in cocaine selectively decreases cocaine demand. Nunez C, et al. Experimental and Clinical Psychopharmacology 2026;34(2):207-215. (Primary outcomes for CTN-0130)
Undervaluing nondrug rewards or overvaluing cocaine? Cocaine demand relates to cocaine use severity more strongly than anhedonia in individuals with cocaine use disorder. Nunez C, et al. Experimental and Clinical Psychopharmacology 2026;33(1):91-99.
Applying machine learning in predicting medication treatment outcomes for opioid use disorder. Balise RR, et al. Journal of Substance Use and Addiction Treatment 2026;183:209847.
“Not a monolith”: Type-specific MOUD awareness and rural willingness among direct service providers and clients. Laschober TC, et al. Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 14-17, 2026. (CTN-0082)
Fentanyl overdose history and cocaine use severity are associated with how people mitigate risks of fentanyl-adulterated cocaine. Anighoro B, et al. Substance Use & Misuse 2026 (in press). (CTN-0130)
Perceived effect of the COVID-19 pandemic on substance use and interest in medications for opioid use disorder and naloxone among people who use opioids in the Southern United States. Laschober TC, et al. Journal of Prevention and Health Promotion 2026 (in press). (CTN-0082)
Emergency department-initiated standard versus high-dose buprenorphine induction (ENVISION): A randomised clinical trial protocol. Hawk K, et al. BMJ Open 2026;16(6):e113762. (CTN-0145)
Characterization of patients declining to participate in opioid overdose prevention clinical research in an emergency department setting. Ward RC, et al. Journal of Substance Use & Addiction Treatment 2026 (in press). (CTN-0107)
Overcoming low representation: Lessons from an integrative data analysis of CTN studies for assessing treatment effectiveness among Black people who use cocaine and/or opioids. Ruglass LM, et al. Journal of Substance Use & Addiction Treatment 2026 (in press). (CTN-0125)
Longitudinal craving profiles in cannabis use disorder: A latent class growth analysis of the achieving cannabis cessation: Evaluating N-Acetylcysteine Treatment (ACCENT) (CTN-0053) trial. Alias-Ferri M, et al. Drug and Alcohol Dependence 2026;285:113208. (CTN-0053)
“We need to keep in mind that battle fatigue”: A commentary on moral injury among substance use treatment and community service providers [commentary]. Saunders EC, et al. Journal of Substance Use & Addiction Treatment (in press).
Posted on May 26, 2026, updated June 17, 2026